Philip Morris
Passive Smoking Affects Endothelium and Platelets
Fields
- Author
- Arnold, J.
- Davis, J.W.
- Shelton, L.
- Watanabe, I.S.
- Davis, J.W.
- Area
- SCIENTIFIC AFFAIRS/BLACK LATERAL OLD S&T
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Master ID
- 2023511661/2307
Related Documents:- 2023511661-2307 Environmental Tobacco Smoke and Heart Disease
- 2023511710 the Relationship of Passive Smoking to Various Health Outcomes Among Seventh-Day Adventists in California.
- 2023511714-1718 Passive Smoking and the Risk of Heart Attack or Coronary Death
- 2023511722-1727 Effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers A Prospective Study
- 2023511728 Erratum
- 2023511729 'effects of Passive Smoking on Ischemic Heart Disease Mortality of Nonsmokers: A Prospective Study'
- 2023511730 the First Author Replies
- 2023511734-1737
- 2023511738-1744 Passive Smoking in Females and Coronary Heart Disease
- 2023511749-1756 Original Contributions Heart Disease Mortality in Nonsmokers Living with Smokers
- 2023511760-1781 Lung Cancer in Japan: Effects of Nutrition and Passive Smoking
- 2023511785-1789 Passive Smoking and Cardiorespiratory Health in A General Population in the West of Scotland
- 2023511790 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511791-1792 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511793-1795 Passive Smoking and Cardiorespiratory Health in Scotland
- 2023511800-1802 Public Health Briefs Passive Smoking and 20-Year Cardiovascular Disease Mortality Among Nonsmoking Wives, Evans County, Georgia
- 2023511806-1816 Relationship of Passive Smoking to Risk of Lung Cancer and Other Smoking-Associated Diseases
- 2023511818 Increased Incidence of Heart Attacks in Nonsmoking Women Married to Smokers
- 2023511822-1824 Cvd Epidemiology Newsletter
- 2023511829-1841 Original Contributions Effects of Passive Smoking in the Multiple Risk Factor Intervention Trial
- 2023511842 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511843-1844 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511845 Re: 'effects of Passive Smoking in the Multiple Risk Factor Intervention Trial'
- 2023511846 the Authors Reply
- 2023511849-1853 Smoking As A Risk Factor for Cerebral Ischemia
- 2023511857-1862 Urinary Cotinine Measurement in Patients with Buerger's Disease - Effects of Active and Passive Smoking on the Disease Process
- 2023511865-1881 An Estimate of Adult Mortality in the United States From Passive Smoking
- 2023511882 Editorial Cardiovascular Risks of Environmental Tobacco Smoke
- 2023511883-1887 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511888-1890 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511891-1892 Ischemic Heart Disease: Response to Lee
- 2023511893-1895 Rebuttal to Lee / Katzenstein Commentary on Passive Smoking Risk
- 2023511896-1899 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response
- 2023511900-1906 An Estimate of Adult Mortality in the United States From Passive Smoking: A Response to Criticism
- 2023511908-1911 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511912 Deaths From Lung Cancer and Ischemic Heart Disease Due to Passive Smoking in New Zealand
- 2023511913 Passive Smoking in New Zealand
- 2023511914 Passive Smoking in New Zealand
- 2023511915 Passive Smoking in New Zealand
- 2023511916 Passive Smoking and Passive Thinking
- 2023511918-1937 Cardiovascular Diseases and the Work Environment A Critical Review of the Epidemiological Literature on Chemical Factors
- 2023511939-1950 Clinical Progress Series Passive Smoking and Heart Disease Epidemiology, Physiology, and Biochemistry
- 2023511952-1957 Review Passive Smoking and the Risk of Heart Disease
- 2023511958-1961 Aha Medical / Scientific Statement Position Statement Environmental Tobacco Smoke and Cardiovascular Disease A Position Paper From the Council on Cardiopulmonary and Critical Care, American Heart Association
- 2023511965-1983 the Health Consequences of Involuntary Smoking A Report of the Surgeon General
- 2023511985-1998 Environmental Tobacco Smoke Measuring Exposures and Assessing Health Effects
- 2023512000-2015 Environmental Tobacco Smoke Proceedings of the International Symposium at Mcgill University 890000 Environmental Tobacco Smoke and Cardiovascular Disease: A Critique of the Epidemiological Literature and Recommendations for Future Research
- 2023512016-2028 Panel Discussion on Cardiovascular Disease
- 2023512030-2037 Indoor Air Quality and Ventilation Environmental Tobacco Smoke (Ets) and Cardiovascular Disease
- 2023512039-2054 A Critique of the Methods Used to Assess the Toxic Effects on Man of Combustion Products.
- 2023512056-2066 Coronary Heart Disease and Involuntary Smoking
- 2023512068-2077 7. Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512079-2088 Environmental Tobacco Smoke and Coronary Heart Disease
- 2023512090-2091 Editorial Give A Dog-End A Bad Name
- 2023512093-2108 Weaknesses in Recent Risk Assessments of Environmental Tobacco Smoke
- 2023512110-2129 Environmental Tobacco Smoke and Mortality A Detailed Review of Epidemiological Evidence Relating Environmental Tobacco Smoke to the Risk of Cancer, Heart Disease and Other Causes of Death in Adults Who Have Never Smoked - 5 Heart Disease
- 2023512131-2155 Environmental Tobacco Smoke Exposure and Occupational Heart Disease
- 2023512157-2171 Passive Smoking and Coronary Artery Disease. Biological Plausibility and Severity of Effect
- 2023512173-2180 Carbon Monoxide and Cardiovascular Disease: An Analysis of the Weight of Evidence
- 2023512185-2189 the Effects of Passive Inhalation of Cigarette Smoke on Excercise Performance
- 2023512192-2195 Effect of Passive Smoking on Angina Pectoris
- 2023512199-2202
- 2023512203-2213 Effect of 'passive' Smoking on the Physical Load Tolerance of Coronary Heart Disease Patients
- 2023512216-2220 Indoor Passive Smoking: Its Effect on Cardiac Performance
- 2023512223-2224 Passive Smoking Severely Decreases Platelet Sensitivity to Antiaggregatory Prostaglandins
- 2023512227-2230 Platelet Sensitivity to Prostacyclin in Smokers and Non-Smokers
- 2023512233-2237 Besitzen Passivraucher Ein Erhohtes Thromboserisiko?
- 2023512247-2253 Lipoprotein and Oxygen Transport Alterations in Passive Smoking Preadolescent Children the Mcv Twin Study
- 2023512256-2257 Abstracts of the 30th Annual Conference on Cardiovascular Disease Epidemiology Children's Hdl-Chol: the Effects of Tobacco: Smoking, Smokeless and Parental Smoking
- 2023512261-2266 Passive Smoking Alters Lipid Profiles in Adolescents
- 2023512269-2274 Serum Lipids & Lipoprotein Profiles of Cigarette Smokers & Passive Smokers
- 2023512278-2279 8th Worldconference on Tobacco or Health Building A Tobacco-Free World 920330 - 920403 Buenos Aires - Argentina Abstracts, Posters and Videos. Serum Lipoproteins in Nonsmokers Chronically Exposed to Tobacco Smoke in the Workplace
- 2023512282 the Association Between Carotid Arterial Wall Thickness and Active and Passive Cigarette Smoking
- 2023512285 Passive Smoking and Carotid Artery Wall Thickness: the Aric Study
- 2023512290-2297 Passive Smoking Increases Experimental Atherosclerosis in Cholesterol-Fed Rabbits
- 2023512300-2301 Supplement to Circulation Abstracts From the 65th Scientific Sessions New Orleans Convention Center New Orleans, Louisiana 921116 - 921119
- 2023512304-2307 Association of Passive Smoking with Increased Coronary Heart Disease Risk Is Not Explained by Elevation of Leucocyte Count
- Document File
- 2023511660/2023512308/Ets: Heart Disease 930900
- Characteristic
- EXTR, EXTRA
- Litigation
- Okag/Privilege Withdrawn
- Okag/Produced
- Named Organization
- Veterans Administration
- Veterans Administration Medical Center
- 50th Annual Scientific Assembly
- American College of Chest Physicians
- American Heart Assn
- Veterans Administration Medical Center
- Author (Organization)
- Arch Intern Med
- Univ of Ks Ks City
- Veterans Administration Medical Center
- Univ of Ks Ks City
- Site
- R529
- Date Loaded
- 24 May 1999
- UCSF Legacy ID
- ijc02a00
Document Images
was withdrawn was 6.9 cm rsther than the 30-cm length used in
our previous studies.°
EndbtMllal CGI1 Counts
(Counts of AnuolMer EndotMlld Gll CarpsaM)
The method of Iiladovec and' Rosemann was used. Nine
millilitet7 of venous blood was collected'in a ailiconized centrifuge
tube that irontained 1 mL of: 3.8% trisodium citrate and mised.
Centrifugstion at 4C and 396 g (middle of the tube) for 20 minutes
removed the erythrocytes and ltukocytea. One milliliter of the
auperrutant was rnixed with 0.2 mL of adenosine S'diphosphate,
disodium salt (1 mg/mL ) andmechanieally shaken for ten minutes.
Another centrifugation at 396 g for 20 minutes removed the
platelet aggregstes. The supernatant was then centrifuged at
2100 g for 20 minutee. After suspension of the sediment in 0.1 mL
of physiologic saline by s" with a ailiconized glass rod, four
Neubauer cliambern were IIlled with the auspension, and the
endothelial cells were counted using phaae-contrast microscopy.
Resultu were expressed as the mean cell count of the four 0.9-µL
chambers.
On two occasions, we evaluated the possibility that the celL
counted as endothelial cells might instead be megakarlrocyte
5ragrnenta. The cells were transferred from the saline suspensions
to glass slides by centrilUgation (Cytospia, Shandon Southern
Instruments, Inc, Birmingham, Ala). The slides were incubated
for 45 minutes with mouse monoclonal anti-human platelet gly-
coprotein lb antibody (Dako Corp, Santa Barbars. Calif) that was
diluted in phosphate-bufferedaaline to a concentration of 16.5 µg
of antibodyprotein per milliliter, washed with phosphate-buffered
aaline, incubated' for 45 minutes with goat anti-mouse IgG fluo-
reseein con,jugate (Boehringer Mannheim. Indianapolis) that was
diluted to a concentration of 94 ~,.g of antibody protein per miililiter,
and washed again. Fluorescence microscopy revealed no nuores-
eence of the endothelial' cell preparations, while simultaneously
processed alides on which human bone marrow aspiraus had been
smeared showed strong IIuotereenee of large cells that were
presumed to be megakaryocytea.
P4esma flleotlne
A portion of the platetet-rieh plasma, prepared in the first
eentrifuption in the procedure for endothelial cell counting, was
kept frozen u- 80'C until it was thawed for extraction and
preparation for gas chromatography by the method of ihyersbend
and Russelll" using an instrument that was equipped with a.
nitrogen-phosphorus detector (Aerograph 14(l0, Varian Instru-
menv Division,, Walnut Creek, Calif). The length of the column
was 90 ctzi. Column temperature was lb0*C. The method was not
otherwise modised' from the original.u The means of duplicate
assays of each aample of plasma were used for statistiesl analyaia.
Carbozytienwqbbin
B, .d was taken into a heprrinised syringe for determination of
the earbozyhemoglobin level by apeetrophotometry (11-2ffi
COo>ometer, Instrumentation L+boriitaries, 1.tunito0. Yaas).
Statletloai AeNyrsir
Two-tailed Wileoxon algoed-rank tests wen used to determine
the significance ofthe diffet+naa between4he means oJthe paired
variablea ahown in the Table andin Figs 1 through 4. ConSdence
intervals oftAe di.dereaoea were calculated aceordint to Gardner
and Altman. p The Spearman rank eorrelation coefficient was used
as a measure of the association between variables.
RlfaJlTS
The Table shows the mean values of each variable before
and after the control period. No siQniScant differences
occurred (P>.2 for each comparisonJ.
Figure 1 shows that the platelet aggregate ratio of eacili
of the ten subjects was lower after than before passive
smoking. The mean values (_ 1 SD) were 0:87 = 0.06 before
and 0.78 t-0.07 after peaive smoking, with a mean differ-
ence of 0.09 and a 96% conIIdenee interval of 0.08 to 0.15.
Figure 2 shows that the endothelial'cell count was always
11111111101 MIIaR t=kif 4100AMb!s*asntItir Cbilol
+..,r.~
14e+ ('a t t0)
Yrelaele Mbn Aflr
Prfalat appapats rfoo ON (=0.06) ON ( t0.0a)
EnetansYil or ourt 2.2 CsoJ) 23
Plaarrr rroolkM ooviaMorf,
0
nw"%L 0
aoo0Gob=yfWq91p0YlAAl.'R 1.1(=o.e) 13 (=0.7)
Fq t-Plate(et aqpnsqats ratios before antl afroer
smokinQ-
Itigber after thaa before passive smoking. Mean values
( z 1 SD) before and after were 2.8 ± 0.9 and 3.7 _ 1.1 per
counting chamber, respectively, with a mean difference of
0.9 per cbamber and a 96% confidence interval of 0 to 1.8
per chamber.
Figure 3 shows that nicotine was not detectable in the
plaama of any subject before passive smoking and was
present in the plasma of all but one subject after completion
of the 20-minute period of passive smolrin`. The mean
conrentration (=1 SD) after passive smoldn8 was
2.8= 1.2nV'mL.
Figure 4 shows that the aarborybemoglobin level was
higher after passive smoking in all but one subjeet, whore
value was uncban*. Yean values ( s 1 SD) were
0.9'b ± 0.396 befott and 1.8%s 0:6% after passive smoking,
with a mean difference of 0.4% and a 95% confidence
interval of 0% to 0.8%. 11
After passive smoldnt, the percent carbozybemo82obia
level did not correlate significantly (P> .60) with the
platelet aggregate ratio or the endotLelial cell count. The
correlation coeffioent between the chanae in the carboxyr-
bemoglobin level from before to after passive smoking and
the corr+eapondine eban8e in the endotDelial cell count was
.78 (P<.01), while the change in the carbozyhemoglobia
level was not aigstiscantly (P>.30) correlated with that of
the platelet aar,e8ate ratio. Neither the plaams nicotine
eonceatration after pe,saive smolriae nor its change from
Arzh tham Med-wt 140, Fwnury 19dp
Pesdve Smo"-Dev(s et sl 38T

7-
J
E
6-
~
c
C7
U
I S-
4-
3-
2-
Paas" Shroluny
Beforn After
P - .002
V
Fip 2.--EndothNial oell oounb be/oee and after passive smokinp.
P.aerye 5rno+tr+p
8ebn ARter,
4-
P- .004
be,Core to after pasai.e smoking was significantly (P>.20)
correlated with the corresponding salues of the platelet
aggnegste ratio or the endotbelial cell eoont.
COMNElff
Hladovec and Rossmann" described a simple method for
the quantitation of anuclear careaases of endotbelial celis
in blood. T'be identity of endothelial cells was based on
Fig 4.--CarboYyfWmoqlobw lev.h Deion and attK passive anqk-
~
their morphologic similarity to cells that were scraped
from the endotheliurn, with the exception that the celL
isolated from blood had' no nuclei. Takahashi and Harker-
added cultured human endothelial cells to blood and recov-
ered: them from mononuclear cell fractions in which they
were identified by the presence of factor VILI-related~
antigen as a cell marker. They detected no end'othelW cellr
in mononuclear cell fractions of venous blood from ten
normal subjecta. Using the method of Hladovec and Fiosa-mann," wC"' found endothelial cetls in the
venous blood of
normal men and women and men with coronary artery
disease. Since, like Hladovec and Rosamann," we saw no
nuclei in these cells, there is no conflict with the report of
'hkaFiaahi and Ha,rker- of the absence of endothelial cellY
from mononuclear cell fractions. In a previous study,' we
identified the anuclear cells as endothelial by their fluorei-
cence after incubation with fluorescein-labeled anti-human
factor VIII-related antigen antibody and by the lack of
fluorescence of therpithelium in simultaneously incubated
sections of human skin.
The present studR showing that brief passive exposure
to tobacco smoke under naturally occurring environmental
conditions has consistent acute effects on the endothelium
and plateleta, was limited to a group of ten healthy male
nonsmokers. It seems likely thst this small group may be
representative of the general population since we observed
similar effects of active smoking on healthy male and
female naive smokess,' healtby male" and female (.IW.D.
and L.S., unpublished data, 1962) habitual smokers, and
male hab9tual~ smokers with coronary artery disease.'.+'
Other workers nsve shown that passive smoking by non-
smokers lowers platelet sensitivity to the antiaggregstory
effect of prost'acyelin.°
Although a statirtically significant correlation between
the change in the endothelial cell count and the change in
the carboxybemoslobm level from before to after p.aai.e
smoking waa found, there was not a sirnificant correlation
between these variablee after passive smoking . We pre.i-
ously found that smoking tobacco cigarettes had a much
greater effect on both platelets and the endotbelinm than
did smoking cigarettes that contained no nicotine.' The
relative importanca of carbon monoxide, nibotine, and the
many other components of tobaoco smoke as eauses of the
3M Ardf In1Kn k1ed-Vd 149, FeOruary 1989 Patsire SmokknQ--Devfa el al

observed effects on platelets and the endothelium remains
unclear.
The significance of enhanced platelet aggregate forma-
tion and an increased'concentration of anuclear carcasaes
of end'othelial' cells in blood' after passive smoking is not
knoaPn. However, both platelet activationf and endothelial
damage+ are prominent among the mechanisms thought to
be involved in atherosclerosis and arterial thrombosis.
Epidemiologic studies are needed to determine whether
repeatad' episodes of passive exposure to tobacco smoke
during a period of years enhance the development of
atherosclerosis and its complications in nonsmokers. A
large .iapanese studh-' indicated that nonsmoking wives of
heavy smokers had a higher risk of developing lung cancer,
while the husbands" smoking habit did: not affect their
wives' risk of dying of ischemic heart disease. Stock'
suggested that Japanese people may be protected from
fatal coronary heart disease by a high dietary intake of
eicosapentaenoic acid. We hope that our work will be an
impetus to the development of epidemiologic investigations
of a possible relationship ~ between passive smoking and
vascular dieeases in Western countriea..
T3ii.ork se suppoKed by s 8rantbom tbe Ameriaan Heart Aseooation,
1Canese Aldliate, lbpeka, and by tke Vstentu Admtnistntion.
IMhf'snOM
I. Strcna JP, Richards YL: Ciauette amolcna aod stheioeeYaoris in
wtopued men: AlAnwcleoai. 197a:23:451176.
2. Arono. W S: Eaea ot eiauette smoking and of' earEon monoade oo
eotonary beart disease. Chest 1Y76:70a14-618.
9. Doll iR'. Peto R: Yortality in relation to amokitr. 20 yean' ab..rv.oon.
oa malk Britiab doctors. B. Yd J Cliw Rea 1976;t 1S2S-1836.
4:, Sannd WB: Update on the toke of eaa.rette amo" in eoxvnary
artery disease. Am fHlart J 1981:101:319-328.
5. Roe. R: The patborenesu of atEeo.eieroaib--an update. N 6wpl J
l/ed 198e:914:4B8-b00.
6: Fluter V. Cbesebro,JH: Aatitbrombotic therapy: Role of plat.eiet-
inhibitor drup: 1. Current eoneepe& of tLromlioaenesie: Role of plateleti.
dfaNo Chw /°roe 1981c56:10p-112.
71 Plero.eky 1. Hladarse J: Suppression of tbe desqnamatittg eCeet of,
smokitg onn the humaa endathelium by bydtosyethylrut4Mdea. Blood
KaN4 1979:16:Y3s-240.
8: Davis JW, Sbelton L. Eiaenber* DA. st ak EQeets of tob.ceo and non-
tobseeo ci8arette smo" on endotbebum aad'plYteiet.. C1iw PAarwacol
Trr 198617t529-633.
9. De.is JW,' Shelton L. Eipnbera DA, et aL Lack of eQeet of i.pirin on
eianrette emoke-induced increase in atevlatinr endotEeLlal eells. Ba.+so-
rlnsu 1B87i17:66-69.
10: Dnia JW, Shelton L. Hutman CR, et el: Smolbn8-iaducYd ehsnaes
in endotbeiium and'platekru ue not asect.d by hydivsy.thyirntosid.s. Br
J Esp PEtAb! 1996:67:766771.
11. Reoaud S. Blacbe D, Dumont E, et al' Platelet fLLOction after ciprette
amokin( ia relation to niootine and'carban matw>ode. Cliw PAar.weol 2ae.
1984:36:38F396.
22 Davis JW, Ht^-- CR. Lewis HD Jr, et aI: Cigarette smohng-
iodueed enhancement of piataot timetion: Lack af prr.ention by aspirin in
men with coronary artery disease. J LaE Clin 8fed'1986:106:479.483.
13. Ho.a UR: Cigarette smoke in elo..d sp.o... L'RVirvw B.aIU
Arsp.er19722117-128.
14: , W nX$, Hosk JC: A ne+ metbod, for the quantitative detection of
plateet aarepw in patientL with arterial iasuffidoqt lawc.t 1974:2.9Y4-
9E6.
1S. Rohr.r TF, PtSstQ B, Weber C. at aL V.liditT of'the Wu-Hoak method
for the qn*».e det.rminaLimn of plwlet aggre8aaon in .i.o. Blrr
1978:J6:IS~20.
16. Kohaaaa FH. Smith 1[H. S.1®ao EW: Do patienta.itb thromboem-
botie di.ea.e bave circulating plas.letaar.gstr' B/aod 1984:64:206200:
17. , Hl.dowe I Reesmann P: CiixuYatina endotbeli.l eelL isolated to-
tetAer with plateiets and the experimental modifleation,of their counu ib,
ran. TA.orwO /P.. 197aa:666-674:
18. Ftiy:rabend C. Rua.eU 1[AEi: Impra..d gsKbromataBrapbie method
and mieroe:tr.etion technique for the measurement of nicvtine in biological
fluids. J PAarm Pko++.oco1 1979:31:73-76.
19. Gardner !Lt Altmaa DG: ConSd.aee internis rather than P.ala.:
Estimation r.thtr than hypotbsis tstialp Br ded J Cli. R.a lYBe1p2:748
750.
20. Takahrbl H. Harker LA_ 1(eaamement of bnmsn endosEeli.l celL
in wboie blood. 7T<+oab R.r 1iBa:91:1-1i
21. Bullrbuber OC. Pttnsensruber C, 9inanaer H', at alf Platelet sensi-
tivity to prostaeyefin in smokm and oon amokera Cbat 1986:90:3f-38.
Z2 Hireyams T: Noo-amo/ona wives of heavy amoken have a tii8har risk
of lung caater. A study 6om Japan. Br N.d J C1iw B.r 1Y81382:18318b.
23. Stock SL: Passive smolong aod nicotine. Laweet 1981t:1044:
PdrrMS Smo+tin¢-aaviY atal aM
Arch trRrrn Mod- Vbi 140, Fobruaer 190

---
